While this may explain the discrepancies between the current and previous studies, Piquemal et al. [5] used an NDRG1 primary antibody which recognized the (EGTRSRSHTS)2 epitope of C-terminal tandem repeat region for Western-blot analysis of U937 (human myelomonocytic cell line), Jurkat (human leukaemic T-cell line) and MCF-7 (human mammary carcinoma cell line) cell lysates. This evidence concerns the gene NDRG1 and breast carcinoma.